+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Long-acting Contraception Market Research Report by Type (Long-Acting Contraceptives and Short-Acting Contraceptives), Product, Application, End-use, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

  • PDF Icon

    Report

  • 249 Pages
  • January 2023
  • Region: Global
  • 360iResearch™
  • ID: 5715566
UP TO OFF until Mar 31st 2023
The Global Long-acting Contraception Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the Global Long-acting Contraception Market.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global Long-acting Contraception Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global Long-acting Contraception Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global Long-acting Contraception Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global Long-acting Contraception Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for the market plan. This research report categorizes the Global Long-acting Contraception Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market is studied across Long-Acting Contraceptives and Short-Acting Contraceptives.
  • Based on Product, the market is studied across Injectables, Intrauterine Devices, and Subdermal Implants.
  • Based on Application, the market is studied across Contraception, HIV, and Schizophrenia.
  • Based on End-use, the market is studied across Drug Store, E-Commerce, and Hospital.
  • Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Long-acting Contraception Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global Long-acting Contraception Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global Long-acting Contraception Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global Long-acting Contraception Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Long-acting Contraception Market, including AbbVie Inc., Bayer AG, DKT International, HRA Pharma SAS by Perrigo Company plc, Merck & Co., Inc., Meril Life Sciences Pvt. Ltd., Mona Lisa N.V., OCON Healthcare, Pfizer Inc., Pregna International Limited, Prosan International B.V., SMB Corporation of India, Teva Pharmaceuticals Industries Ltd., The Cooper Companies, Inc., and Viatris Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Long-acting Contraception Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Long-acting Contraception Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Long-acting Contraception Market?
4. What is the competitive strategic window for opportunities in the Global Long-acting Contraception Market?
5. What are the technology trends and regulatory frameworks in the Global Long-acting Contraception Market?
6. What is the market share of the leading vendors in the Global Long-acting Contraception Market?
7. What modes and strategic moves are considered suitable for entering the Global Long-acting Contraception Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising adoption of long term contraception among male and female
5.1.1.2. Rising publicly funded family planning services
5.1.2. Restraints
5.1.2.1. Associated side effects of long term contraception
5.1.3. Opportunities
5.1.3.1. Introduction of technically advanced long term contraception methods
5.1.3.2. Strong government support for LTC
5.1.4. Challenges
5.1.4.1. Concern regarding limited approved products
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Long-acting Contraception Market, by Type
6.1. Introduction
6.2. Long-Acting Contraceptives
6.3. Short-Acting Contraceptives

7. Long-acting Contraception Market, by Product
7.1. Introduction
7.2. Injectables
7.3. Intrauterine Devices
7.4. Subdermal Implants

8. Long-acting Contraception Market, by Application
8.1. Introduction
8.2. Contraception
8.3. HIV
8.4. Schizophrenia

9. Long-acting Contraception Market, by End-use
9.1. Introduction
9.2. Drug Store
9.3. E-Commerce
9.4. Hospital

10. Americas Long-acting Contraception Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Long-acting Contraception Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Long-acting Contraception Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Product Portfolio Analysis, By Key Player
13.5. Competitive Scenario
13.5.1. Merger & Acquisition
13.5.2. Agreement, Collaboration, & Partnership
13.5.3. New Product Launch & Enhancement
13.5.4. Investment & Funding
13.5.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. AbbVie Inc.
14.2. Bayer AG
14.3. DKT International
14.4. HRA Pharma SAS by Perrigo Company plc
14.5. Merck & Co., Inc.
14.6. Meril Life Sciences Pvt. Ltd.
14.7. Mona Lisa N.V.
14.8. OCON Healthcare
14.9. Pfizer Inc.
14.10. Pregna International Limited
14.11. Prosan International B.V.
14.12. SMB Corporation of India
14.13. Teva Pharmaceuticals Industries Ltd.
14.14. The Cooper Companies, Inc.
14.15. Viatris Inc.

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing


List of Figures
FIGURE 1. GLOBAL LONG-ACTING CONTRACEPTION MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, 2022 VS 2030
FIGURE 3. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL LONG-ACTING CONTRACEPTION MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2030
FIGURE 7. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 8. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL LONG-ACTING CONTRACEPTION MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 10. GLOBAL LONG-ACTING CONTRACEPTION MARKET DYNAMICS
FIGURE 11. GLOBAL LONG-ACTING CONTRACEPTION MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 13. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL LONG-ACTING CONTRACEPTION MARKET COMPETITIVE STRATEGIC WINDOW, BY TYPE, 2030
FIGURE 15. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY LONG-ACTING CONTRACEPTIVES, 2018-2030 (USD MILLION)
FIGURE 16. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY SHORT-ACTING CONTRACEPTIVES, 2018-2030 (USD MILLION)
FIGURE 17. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 18. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL LONG-ACTING CONTRACEPTION MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT, 2030
FIGURE 20. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLES, 2018-2030 (USD MILLION)
FIGURE 21. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2030 (USD MILLION)
FIGURE 22. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY SUBDERMAL IMPLANTS, 2018-2030 (USD MILLION)
FIGURE 23. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 24. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 25. GLOBAL LONG-ACTING CONTRACEPTION MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2030
FIGURE 26. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
FIGURE 27. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY HIV, 2018-2030 (USD MILLION)
FIGURE 28. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY SCHIZOPHRENIA, 2018-2030 (USD MILLION)
FIGURE 29. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2022 VS 2030 (%)
FIGURE 30. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 31. GLOBAL LONG-ACTING CONTRACEPTION MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USE, 2030
FIGURE 32. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY DRUG STORE, 2018-2030 (USD MILLION)
FIGURE 33. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
FIGURE 34. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
FIGURE 35. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 36. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 37. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 38. AMERICAS LONG-ACTING CONTRACEPTION MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 39. ARGENTINA LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 40. BRAZIL LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 41. CANADA LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 42. MEXICO LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 43. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 44. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 45. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 46. UNITED STATES LONG-ACTING CONTRACEPTION MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 47. ASIA-PACIFIC LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 48. ASIA-PACIFIC LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 49. ASIA-PACIFIC LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 50. ASIA-PACIFIC LONG-ACTING CONTRACEPTION MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 51. AUSTRALIA LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 52. CHINA LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 53. INDIA LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 54. INDONESIA LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 55. JAPAN LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 56. MALAYSIA LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 57. PHILIPPINES LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 58. SINGAPORE LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 59. SOUTH KOREA LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 60. TAIWAN LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 61. THAILAND LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 62. VIETNAM LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 63. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 64. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 65. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 66. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 67. DENMARK LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 68. EGYPT LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 69. FINLAND LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 70. FRANCE LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 71. GERMANY LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 72. ISRAEL LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 73. ITALY LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 74. NETHERLANDS LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 75. NIGERIA LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 76. NORWAY LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 77. POLAND LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 78. QATAR LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 79. RUSSIA LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 80. SAUDI ARABIA LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 81. SOUTH AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 82. SPAIN LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 83. SWEDEN LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 84. SWITZERLAND LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 85. TURKEY LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 86. UNITED ARAB EMIRATES LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 87. UNITED KINGDOM LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 88. GLOBAL LONG-ACTING CONTRACEPTION MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 89. GLOBAL LONG-ACTING CONTRACEPTION MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 90. GLOBAL LONG-ACTING CONTRACEPTION MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022


List of Tables
TABLE 1. GLOBAL LONG-ACTING CONTRACEPTION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY LONG-ACTING CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY LONG-ACTING CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY LONG-ACTING CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY SHORT-ACTING CONTRACEPTIVES, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY SHORT-ACTING CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY SHORT-ACTING CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLES, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY INTRAUTERINE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY SUBDERMAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY SUBDERMAL IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY SUBDERMAL IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY CONTRACEPTION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY CONTRACEPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY CONTRACEPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY HIV, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY HIV, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY HIV, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY SCHIZOPHRENIA, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY SCHIZOPHRENIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY SCHIZOPHRENIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY DRUG STORE, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY DRUG STORE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY DRUG STORE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY E-COMMERCE, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL LONG-ACTING CONTRACEPTION MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 59. CANADA LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 60. CANADA LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61. CANADA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. CANADA LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. CANADA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 64. MEXICO LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 65. MEXICO LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. MEXICO LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. MEXICO LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. MEXICO LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 76. ASIA-PACIFIC LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. ASIA-PACIFIC LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 81. AUSTRALIA LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 82. AUSTRALIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. AUSTRALIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. AUSTRALIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. AUSTRALIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 86. CHINA LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 87. CHINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. CHINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. CHINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. CHINA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 91. INDIA LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 92. INDIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. INDIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. INDIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. INDIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 96. INDONESIA LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 97. INDONESIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 98. INDONESIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. INDONESIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. INDONESIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 101. JAPAN LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 102. JAPAN LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. JAPAN LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. JAPAN LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. JAPAN LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 106. MALAYSIA LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 107. MALAYSIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 108. MALAYSIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. MALAYSIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. MALAYSIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 111. PHILIPPINES LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 112. PHILIPPINES LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. PHILIPPINES LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. PHILIPPINES LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. PHILIPPINES LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 116. SINGAPORE LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 117. SINGAPORE LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. SINGAPORE LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. SINGAPORE LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. SINGAPORE LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 121. SOUTH KOREA LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 122. SOUTH KOREA LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 123. SOUTH KOREA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 124. SOUTH KOREA LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. SOUTH KOREA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 126. TAIWAN LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 127. TAIWAN LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 128. TAIWAN LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 129. TAIWAN LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. TAIWAN LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 131. THAILAND LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 132. THAILAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. THAILAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 134. THAILAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. THAILAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 136. VIETNAM LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 137. VIETNAM LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 138. VIETNAM LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. VIETNAM LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. VIETNAM LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 147. DENMARK LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 148. DENMARK LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 149. DENMARK LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 150. DENMARK LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. DENMARK LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 152. EGYPT LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 153. EGYPT LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 154. EGYPT LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. EGYPT LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. EGYPT LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 157. FINLAND LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 158. FINLAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 159. FINLAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 160. FINLAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. FINLAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 162. FRANCE LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 163. FRANCE LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 164. FRANCE LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 165. FRANCE LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. FRANCE LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 167. GERMANY LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 168. GERMANY LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 169. GERMANY LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 170. GERMANY LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. GERMANY LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 172. ISRAEL LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 173. ISRAEL LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 174. ISRAEL LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 175. ISRAEL LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. ISRAEL LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 177. ITALY LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 178. ITALY LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 179. ITALY LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. ITALY LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. ITALY LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 182. NETHERLANDS LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 183. NETHERLANDS LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 184. NETHERLANDS LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 185. NETHERLANDS LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. NETHERLANDS LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 187. NIGERIA LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 188. NIGERIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 189. NIGERIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 190. NIGERIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. NIGERIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 192. NORWAY LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 193. NORWAY LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 194. NORWAY LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 195. NORWAY LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. NORWAY LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 197. POLAND LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 198. POLAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 199. POLAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 200. POLAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. POLAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 202. QATAR LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 203. QATAR LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 204. QATAR LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 205. QATAR LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. QATAR LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 207. RUSSIA LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 208. RUSSIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 209. RUSSIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 210. RUSSIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. RUSSIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 212. SAUDI ARABIA LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 213. SAUDI ARABIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 214. SAUDI ARABIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 215. SAUDI ARABIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. SAUDI ARABIA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 217. SOUTH AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 218. SOUTH AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 219. SOUTH AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 220. SOUTH AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. SOUTH AFRICA LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 222. SPAIN LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 223. SPAIN LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 224. SPAIN LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 225. SPAIN LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. SPAIN LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 227. SWEDEN LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 228. SWEDEN LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 229. SWEDEN LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 230. SWEDEN LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. SWEDEN LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 232. SWITZERLAND LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 233. SWITZERLAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 234. SWITZERLAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 235. SWITZERLAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. SWITZERLAND LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 237. TURKEY LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 238. TURKEY LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 239. TURKEY LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 240. TURKEY LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 241. TURKEY LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 242. UNITED ARAB EMIRATES LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 243. UNITED ARAB EMIRATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 244. UNITED ARAB EMIRATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 245. UNITED ARAB EMIRATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 246. UNITED ARAB EMIRATES LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM LONG-ACTING CONTRACEPTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 248. UNITED KINGDOM LONG-ACTING CONTRACEPTION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM LONG-ACTING CONTRACEPTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 250. UNITED KINGDOM LONG-ACTING CONTRACEPTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM LONG-ACTING CONTRACEPTION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 252. GLOBAL LONG-ACTING CONTRACEPTION MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 253. GLOBAL LONG-ACTING CONTRACEPTION MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 254. GLOBAL LONG-ACTING CONTRACEPTION MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 255. GLOBAL LONG-ACTING CONTRACEPTION MARKET RANKING, BY KEY PLAYER, 2022
TABLE 256. GLOBAL LONG-ACTING CONTRACEPTION MARKET SHARE, BY KEY PLAYER, 2022
TABLE 257. GLOBAL LONG-ACTING CONTRACEPTION MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 258. GLOBAL LONG-ACTING CONTRACEPTION MARKET MERGER & ACQUISITION
TABLE 259. GLOBAL LONG-ACTING CONTRACEPTION MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 260. GLOBAL LONG-ACTING CONTRACEPTION MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 261. GLOBAL LONG-ACTING CONTRACEPTION MARKET INVESTMENT & FUNDING
TABLE 262. GLOBAL LONG-ACTING CONTRACEPTION MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 263. GLOBAL LONG-ACTING CONTRACEPTION MARKET: LICENSE & PRICING

Companies Mentioned

  • AbbVie Inc.
  • Bayer AG
  • DKT International
  • HRA Pharma SAS by Perrigo Company plc
  • Merck & Co., Inc.
  • Meril Life Sciences Pvt. Ltd.
  • Mona Lisa N.V.
  • OCON Healthcare
  • Pfizer Inc.
  • Pregna International Limited
  • Prosan International B.V.
  • SMB Corporation of India
  • Teva Pharmaceuticals Industries Ltd.
  • The Cooper Companies, Inc.
  • Viatris Inc.

Methodology

Loading
LOADING...